COMMUNIQUÉS West-GlobeNewswire

-
AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders
27/05/2025 -
NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update
27/05/2025 -
Forte Medical Revolutionises Women’s Routine Health with Peezy Midstream
27/05/2025 -
Altamira Therapeutics Announces Collaboration on Circular RNA Delivery
27/05/2025 -
VIVUS Announces QSYMIA® Now Available at Costco Pharmacies Nationwide
27/05/2025 -
Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu
27/05/2025 -
HiberCell Announces Successful Completion of Dose Escalation and Enrollment Update for Ph1b Study Evaluating HC-7366 in Combination with WELIREG® (belzutifan) in Advanced ccRCC
27/05/2025 -
Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors
27/05/2025 -
New Survey Shows Physician Appointment Wait Times Surge: 19% Since 2022, 48% Since 2004
27/05/2025 -
30 years of Innovation and Impact: Dan Larson's Inspiring Story
27/05/2025 -
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29
27/05/2025 -
Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale
27/05/2025 -
Genmab to Participate in a Fireside Chat at the 46th Goldman Sachs Annual Global Healthcare Conference
27/05/2025 -
Catheter Precision, Inc. Receives CE Mark for LockeT
27/05/2025 -
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense
27/05/2025 -
Avalo Therapeutics to Participate in Upcoming Investor Conferences
27/05/2025 -
Strüngmann Award Committee Announces 2025 Finalists Recognizing Outstanding Life Science Entrepreneurs in the DACH Region
27/05/2025 -
EDAP to Present at the Jefferies Global Healthcare Conference
27/05/2025 -
Augustine Therapeutics announces first patient dosed in Phase I clinical trial evaluating lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth disease
27/05/2025
Pages